TransCode Therapeutics, Inc. Common Stock

RNAZNASDAQUSD
8.40 USD
0.05 (0.59%)AT CLOSE (11:59 AM EDT)
8.40
0.08 (0.89%)
POST MARKET (AS OF 04:48 PM EDT)
Post Market
AS OF 04:48 PM EDT
8.40
0.08 (0.89%)
🟢Market: OPEN
Open?$8.30
High?$8.54
Low?$8.17
Prev. Close?$8.45
Volume?10.1K
Avg. Volume?6.5K
VWAP?$8.28
Rel. Volume?1.56x
Bid / Ask
Bid?$6.97 × 100
Ask?$11.40 × 100
Spread?$4.43
Midpoint?$9.19
Valuation & Ratios
Market Cap?7.7M
Shares Out?917.0K
Float?832.6K
Float %?90.8%
P/E Ratio?N/A
P/B Ratio?0.75
EPS?-$39.56
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.29Strong
Quick Ratio?6.29Strong
Cash Ratio?5.10Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.75CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
0.5CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-350.9%WEAK
ROA?
-22.3%WEAK
Cash Flow & Enterprise
FCF?$-19522889
Enterprise Value?$-10065141
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Employees
12
Market Cap
7.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-09
Address
6 LIBERTY SQUARE
BOSTON, MA 02109
Phone: 857-301-6857